Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Tuesday 31 July, 2007

Lipoxen PLC

Award of share options

Lipoxen PLC
31 July 2007


                    Lipoxen Plc ('Lipoxen' or 'the Company')

                             Award of share options


London, UK, 31 July, 2007 - Lipoxen plc, a biopharmaceutical company
specialising in the development of high value differentiated biologicals,
vaccines and oncology drugs, today announces that Colin Hill, Finance Director
of the Company has been awarded a total of 400,000 share options in the Company
exercisable at a price of 47.75 pence per share and vesting as noted below:

200,000 options exercisable at 47.75 pence per share vesting immediately
200,000 options exercisable at 47.75 pence per share vesting on 31 July 2008


Enquiries:

Lipoxen PLC  
M. Scott Maguire, CEO                                        +44 (0)20 7691 3583

Grant Thornton Corporate Finance
Philip J Secrett                                             +44 (0)20 7383 5100

Citigate Dewe Rogerson
Yvonne Alexander                                             +44 (0)20 7638 9571



                      This information is provided by RNS
            The company news service from the London Stock Exchange